Pathology
 |
|
4 july 2019 15:02:34 |
| Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong`s perspective (Prostate Cancer and Prostatic Diseases) |
|
Tweet |
| 185 viewsCategory: Oncology, Pathology |
Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment (Prostate Cancer and Prostatic Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
